Keyphrases
Metabolic Pathway
100%
Antiviral Agents
100%
Herpes Simplex Virus Type 1 (HSV-1)
100%
Vero Cells
100%
Ganciclovir
100%
Novel Antivirals
100%
Infected Cells
36%
Triphosphate
36%
Viral Infection
18%
Diphosphorylation
18%
Time Dependence
9%
Uninfected Cells
9%
Phosphate
9%
Rate-limiting Step
9%
Highly Effective
9%
Incubation
9%
Diphosphate
9%
Long Half-life
9%
Decay Rate
9%
Antiviral Activity
9%
Herpes Simplex Virus 2 (HSV-2)
9%
Cytotoxic Effect
9%
Accumulation Rate
9%
Highly Selective
9%
Thymidine Analogs
9%
Monophosphate
9%
HSV-TK
9%
Pseudosugar
9%
Herpesvirus
9%
Dose Dependence
9%
Antiherpetic Activity
9%
Antiherpetic
9%
Plaque Reduction Assay
9%
CC50
9%
Medicine and Dentistry
Antivirus Agent
100%
Metabolism
100%
Ganciclovir
100%
Human Alphaherpesvirus 1
100%
Vero Cell
100%
Virus Infection
18%
Metabolite
9%
Infection
9%
Cytotoxicity
9%
Antiviral Activity
9%
Incubation
9%
Thymidine
9%
Herpesviridae
9%
Herpes Simplex Virus 2
9%
Pyrophosphoric Acid Derivative
9%
Neuroscience
Metabolic Pathway
100%
Herpes Simplex Virus
100%
Ganciclovir
100%
Antivirals
100%
Vero Cell
100%
Thymidine
9%
Cytotoxicity
9%
Herpesviridae
9%
Immunology and Microbiology
Metabolism
100%
Human Alphaherpesvirus 1
100%
Viral Disease
20%
Cytotoxicity
10%
Antiviral Activity
10%
Metabolite
10%
Herpes Simplex Virus 2
10%
Conformation
10%
Herpesviridae
10%
CC50
10%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Human Alphaherpesvirus 1
100%
Metabolite
10%
Conformation
10%
Cytotoxicity
10%
Thymidine
10%
Herpesviridae
10%
Antiviral Activity
10%
Herpes Simplex Virus 2
10%
CC50
10%